Generic from Novalgina

The generic name for novalgine is sodium dipyrone, which is the main component of this medicine in the Sanofi-Aventis laboratory. Sodium dipyrone, in its generic version, is also manufactured by several pharmaceutical laboratories such as Medley, Eurofarma, EMS, Neo Química.

The generic novalgine is indicated as analgesic and antipyretic and can be found in tablet forms, suppositories or injectable solution.

Indications

Pain and fever.

Contraindications

Patients with hypersensitivity to dipyrone or any component of the formula, pregnancy, breastfeeding, asthma, 6-phosphate dehydrogenase deficiency, children under 3 months or less than 5 kg, children under 4 years (suppository), Children with less than 1 year (intravenous), porphyria, allergic reaction to drugs, allergy to pyrazolonic derivatives, chronic respiratory infection.

Adverse effects

There may be haematological reactions (reduction of white blood cells), transient low blood pressure, skin manifestations (rash). In isolated cases, Stevens-Johnson syndrome or Lyell's syndrome.

How to use

Oral use

• Tablet 1000 mg:
  • Adults and adolescents over 15 years: ½ tablet up to 4 times a day or 1 tablet
    up to 4 times a day.
• Tablet 500 mg
  • Adults and adolescents over 15 years: 1 to 2 tablets up to 4 times a day.
• Drops:
  • Adults and adolescents over 15 years of age:
    • 20 to 40 drops in single administration or up to a maximum of 40 drops 4 times a day.
  • Children:
    • Weight (average age) Dose Drops
      5 to 8 kg single dose 2 to 5 / (3 to 11 months) maximum dose 20 (4 x 5) daily
    • 9 to 15 kg single dose 3 to 10 / (1 to 3 years) maximum dose 40 (4 x 10) daily
    • 16 to 23 kg single dose 5 to 15 / (4 to 6 years) maximum dose 60 (4 x 15) daily
    • 24 to 30 kg single dose 8 to 20 / (7 to 9 years) maximum dose 80 (4 x 20) daily
    • 31 to 45 kg single dose 10 to 30 / (10 to 12 years) maximum dose 120 (4 x 30) daily
    • 46 to 53 kg single dose 15 to 35 / (13 to 14 years) maximum dose 140 (4 x 35) daily
  • Children younger than 3 months of age or weighing less than 5 kg should not be treated with Novalgina unless absolutely necessary.

Retal Usage

• Adults and adolescents over 15 years: 1 suppository up to 4 times a day.
• Children over 4 years: 1 suppository up to 4 times a day.
• Children younger than 4 years or under 16 kg should not be treated with suppositories.

Injectable Use

• Adults and adolescents over 15 years: single dose of 2 to 5 ml (intravenous or intramuscular); maximum daily dose of 10 ml.
• Children and infants: Injectable NOVALGIN should be administered intramuscularly only at 1 year of age.
• Children
  • Infants 5-8 kg - 0.1 - 0.2 ml
  • Children 9 to 15 kg 0.2 - 0.5 ml 0.2 - 0.5 ml
  • Children 16-23 kg 0.3 - 0.8 ml 0.3 - 0.8 ml
  • Children 24 to 30 kg 0.4 - 1 ml 0.4 - 1 ml
  • Children from 31 to 45 kg 0.5 - 1.5 ml 0.5 - 1.5 ml
  • Children 46 to 53 kg 0.8 - 1.8 ml 0.8 - 1.8 ml

Doses given should be directed by your doctor.